|
FUCA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43399966848301E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54282000000006E-05 |
| Normal-vs-Stage2 |
6.264200E-03 |
| Normal-vs-Stage3 |
4.200100E-04 |
| Normal-vs-Stage4 |
1.626030E-02 |
| Stage1-vs-Stage2 |
1.216990E-01 |
| Stage1-vs-Stage3 |
3.919700E-02 |
| Stage1-vs-Stage4 |
1.267160E-01 |
| Stage2-vs-Stage3 |
5.507200E-01 |
| Stage2-vs-Stage4 |
8.236800E-01 |
| Stage3-vs-Stage4 |
7.797400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7707999511174E-09 |
| Normal-vs-AfricanAmerican |
2.01659999999881E-05 |
| Normal-vs-Asian |
3.173000E-01 |
| Caucasian-vs-AfricanAmerican |
2.412000E-01 |
| Caucasian-vs-Asian |
7.678000E-01 |
| AfricanAmerican-vs-Asian |
9.657600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.26670001949259E-09 |
| Normal-vs-Female |
3.4690000000337E-06 |
| Male-vs-Female |
1.092380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.830500E-04 |
| Normal-vs-Extreme_Weight |
7.969700E-04 |
| Normal-vs-Obese |
6.43120000032305E-07 |
| Normal-vs-Extreme_Obese |
2.394400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.733900E-02 |
| Normal_Weight-vs-Obese |
4.733000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.842600E-01 |
| Extreme_Weight-vs-Obese |
1.780450E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.399000E-01 |
| Obese-vs-Extreme_Obese |
7.432000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.021740E-02 |
| Normal-vs-Age(41-60Yrs) |
3.38610000039097E-08 |
| Normal-vs-Age(61-80Yrs) |
3.85290000015637E-07 |
| Normal-vs-Age(81-100Yrs) |
3.036100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.169200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.071380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.074200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.616960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.124200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.896000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.28770000218381E-08 |
| Normal-VS-Type2 PRCC |
3.2880000000457E-06 |
| Normal-VS-KIRP CIMP |
1.312230E-02 |
| Normal-VS-Unclassified PRCC |
3.040300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.477640E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.932500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.795800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.153500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.441200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.987800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.433600E-04 |
| Normal-vs-N1 |
1.444760E-04 |
| Normal-vs-N2 |
8.915600E-01 |
| N0-vs-N1 |
2.138600E-01 |
| N0-vs-N2 |
2.710000E-01 |
| N1-vs-N2 |
8.401500E-02 |
|
|
